Validation of STA-Liatest D-Di assay for exclusion of pulmonary embolism according to the latest Clinical and Laboratory Standard Institute/Food and Drug Administration guideline. Results of a multicenter management study

Blood Coagulation and Fibrinolysis

Volumn 28, Issue 3, 2017, Pages 254-260

  Pernod, Gilles ^a   Wu, Haifeng ^b   De Maistre, Emmanuel ^c   Lazarchick, John ^d   Kassis, Jeannine ^e   Aguilar, Carlos ^f   Vera, Pascual M ^g   Palareti, Gualtiero ^h   D'Angelo, Armando ⁱ   Caterino, Jeffrey ^j   Dutrillaux, Fabienne ^j   Headden, Gary ^j   Kaide, Colin ^j   Maignan, Maxime ^j   Marlu, Raphaël ^j   Richard, Anais ^j   Tissier, Cindy ^j  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b OHIO STATE UNIVERSITY   (United States)

^c DIJON UNIVERSITY HOSPITAL   (France)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^f HOSPITAL SANTA BÁRBARA   (Spain)

^g HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^h UNIVERSITY OF BOLOGNA   (Italy)

ⁱ SAN RAFFAELE HOSPITAL   (Italy)

^j NONE

more..

Author keywords

Clinical and Laboratory Standard Institute; D dimer; Food and Drug Administration; pulmonary embolism; STA Liatest D Di

Indexed keywords

D DIMER; FIBRINOGEN; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ADULT; ARTICLE; BLOOD EXAMINATION; CLINICAL LABORATORY; CLINICAL OUTCOME; CLINICAL PRETEST PROBABILITY; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HEALTH CARE QUALITY; HUMAN; IMMUNOASSAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MIDDLE AGED; MULTICENTER STUDY; OUTPATIENT; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; STA LIATEST D DIMER ASSAY; THROMBOCYTE FUNCTION ANALYZER; VALIDATION STUDY; BIOASSAY; CLINICAL TRIAL; FEMALE; MALE; METABOLISM; PROCEDURES; PULMONARY EMBOLISM; UNITED STATES;

BIOLOGICAL ASSAY; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84978718189     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0000000000000591     Document Type: Article

References (24)

1. Mos IC, Douma RA, Erkens PM, Kruip MJ, Hovens MM, van Houten AA, et al. Diagnostic outcome management study in patients with clinically suspected recurrent acute pulmonary embolism with a structured algorithm. Thromb Res 2014; 133:1039-1044.
2. Hwang HG, Schulman S. Respiratory review of 2013: pulmonary thromboembolism. Tuberc Respir Dis (Seoul) 2013; 75:89-94.
3. Bates SM, Jaeschke R, Stevens SM, Goodacre S, Wells PS, Stevenson MD, et al. Diagnosis of DVT: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e351S-e418S.
4. Di Nisio M, Squizzato A, Rutjes AW, Buller HR, Zwinderman AH, Bossuyt PM. Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review. J Thromb Haemost 2007; 5:296-304.
5. Stein PD, Hull RD, Patel KC, Olson RE, Ghali WA, Brant R, et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med 2004; 140:589-602.
6. Freyburger G, Labrouche S. Comparability of D-dimer assays in clinical samples. Semin Vasc Med 2005; 5:328-339.
7. Clinical and Laboratory Standards Institute (CLSI). Quantitative D-dimer for exclusion of venous thromboembolic disease; approved guideline. CLSI document H59-A (ISBN 1-56238-747-2). Clinical and Laboratory Standard Institute, 940 West Valley Road, Suite 1400, Wayne, PA 19087 USA, 2011.
8. Wells PS, Anderson DR, Ginsberg J. Assessment of deep vein thrombosis or pulmonary embolism by the combined use of clinical model and noninvasive diagnostic tests. Semin Thromb Hemost 2000; 26:643-656.
9. Wells PS. Integrated strategies for the diagnosis of venous thromboembolism. J Thromb Haemost 2007; 5 (Suppl 1):41-50.
10. Clinical and Laboratory Standards Institute (CLSI). Collection, transport, and processing of blood specimens for testing plasma-based coagulation assay and molecular hemostasis assays; approved guideline-fifth edition. CLSI document H21-A5 (ISBN 1-56238-657-3). Clinical and Laboratory Standard Institute, 940 West Valley Road, Suite 1400, Wayne, PA 19087 USA, 2008.
11. van der Graaf F, van den Borne H, van der Kolk M, de Wild PJ, Janssen GW, van Uum SH. Exclusion of deep venous thrombosis with D-dimer testing: comparison of 13 D-dimer methods in 99 outpatients suspected of deep venous thrombosis using venography as reference standard. Thromb Haemost 2000; 83:191-198.
12. Schrecengost JE, LeGallo RD, Boyd JC, Moons KG, Gonias SL, Rose CE Jr, et al. Comparison of diagnostic accuracies in outpatients and hospitalized patients of D-dimer testing for the evaluation of suspected pulmonary embolism. Clin Chem 2003; 49:1483-1490.
13. Engelhardt W, Palareti G, Legnani C, Gringel E. Comparative evaluation of D-dimer assays for exclusion of deep venous thrombosis in symptomatic outpatients. Thromb Res 2003; 112:25-32.
14. Anderson DR, Wells PS, Stiell I, MacLeod B, Simms M, Gray L, et al. Management of patients with suspected deep vein thrombosis in the emergency department: combining use of a clinical diagnosis model with D-dimer testing. J Emerg Med 2000; 19:225-230.
15. Le Gal G, Righini M, Roy PM, Sanchez O, Aujesky D, Bounameaux H, et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med 2006; 144:165-171.
16. Kline JA, Courtney DM, Kabrhel C, Moore CL, Smithline HA, Plewa MC, et al. Prospective multicenter evaluation of the pulmonary embolism rule-out criteria. J Thromb Haemost 2008; 6:772-780.
17. Scarvelis D, Palareti G, Toulon P, Wells PS, Wu JR. HemosIL D-dimer HS assay in the diagnosis of deep vein thrombosis and pulmonary embolism. Results of a multicenter management study. J Thromb Haemost 2008; 6:1973-1975.
18. Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galie N, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014; 35:3033-3069.
19. Konstantinides S, Torbicki A. Management of venous thrombo-embolism: an update. Eur Heart J 2014; 35:2855-2863.
20. Reber G, de Moerloose P. Standardization of D-dimer testing. In: Kitchen S, Olson JD, Preston FE, editors. Quality in laboratory hemostasis and thrombosis. Hoboken, NJ: Wiley-Blackwell Ltd; 2009. pp. 99-109.
21. Legnani C, Cini M, Scarvelis D, Toulon P, Wu JR, Palareti G. Multicenter evaluation of a new quantitative highly sensitive D-dimer assay, the Hemosil D-dimer HS 500, in patients with clinically suspected venous thromboembolism. Thromb Res 2010; 125:398-401.
22. de Moerloose P, Palareti G, Aguilar C, Legnani C, Reber G, Peetz D. A multicenter evaluation of a new quantitative highly sensitive D-dimer assay for exclusion of venous thromboembolism. Thromb Haemost 2008; 100:505-512.
23. Boeer K, Siegmund R, Schmidt D, Deufel T, Kiehntopf M. Comparison of six D-dimer assays for the detection of clinically suspected deep venous thrombosis of the lower extremities. Blood Coagul Fibrinolysis 2009; 20:141-145.
24. Righini M, Perrier A, De Moerloose P, Bounameaux H. D-Dimer for venous thromboembolism diagnosis: 20 years later. J Thromb Haemost 2008; 6:1059-1071.